← Back to News

Various

Analyst Upgrades and Downgrades For the Week of August 12th

Analyst upgrades, downgrades, and more

By Justin Nugent · August 12, 2024
Analyst Upgrades and Downgrades For the Week of August 12th

August 16th Upgrades, Downgrades, and More

Upgrades – Friday, August 16, 2024

  • AFC Gamma (AFCG)
    • Brokerage Firm: Compass Point
    • Ratings Change: Sell >> Neutral
    • Price Target: $10 >> $9
  • CF Industries (CF)
    • Brokerage Firm: Barclays
    • Ratings Change: Equal Weight >> Overweight
    • Price Target: $80 >> $90
  • Cisco (CSCO)
    • Brokerage Firm: HSBC Securities
    • Ratings Change: Hold >> Buy
    • Price Target: $46 >> $58
  • Fox Corporation (FOXA)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Underweight >> Overweight
    • Price Target: $29 >> $46
  • Illumina (ILMN)
    • Brokerage Firm: Daiwa Securities
    • Ratings Change: Neutral >> Buy
    • Price Target: $120 >> $154
  • Kimco Realty (KIM)
    • Brokerage Firm: Raymond James
    • Ratings Change: Market Perform >> Strong Buy
    • Price Target: $25
  • Kite Realty (KRG)
    • Brokerage Firm: Raymond James
    • Ratings Change: Market Perform >> Strong Buy
    • Price Target: $28
  • Microchip (MCHP)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Neutral >> Overweight
    • Price Target: $90 >> $100
  • Newmark Group (NMRK)
    • Brokerage Firm: Wolfe Research
    • Ratings Change: Peer Perform >> Outperform
    • Price Target: $15
  • Sphere Entertainment Co. (SPHR)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Neutral >> Overweight
    • Price Target: $37 >> $57
  • Teradyne (TER)
    • Brokerage Firm: Cantor Fitzgerald
    • Ratings Change: Neutral >> Overweight
    • Price Target: $16
  • Origin Materials (ORGN)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Neutral >> Buy
    • Price Target: $1.35 >> $3
  • EnLink Midstream (ENLC)
    • Brokerage Firm: Tudor, Pickering, Holt & Co.
    • Ratings Change: Hold >> Buy
    • Price Target: $15
  • JD.com (JD)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Neutral >> Overweight
    • Price Target: $33 >> $36
  • Alnylam Pharma (ALNY)
    • Brokerage Firm: Goldman
    • Ratings Change: Neutral >> Buy
    • Price Target: $198 >> $370
  • CI&T Inc (CINT)
    • Brokerage Firm: Itau BBA
    • Ratings Change: Market Perform >> Outperform

Downgrades – Friday, August 16, 2024

  • Bumble Inc. (BMBL)
    • Brokerage Firm: TD Cowen
    • Ratings Change: Buy >> Hold
    • Price Target: $22 >> $7.5
  • CAE (CAE)
    • Brokerage Firm: Morgan Stanley
    • Ratings Change: Overweight >> Equal-Weight
  • Coherus BioSciences (CHRS)
    • Brokerage Firm: UBS
    • Ratings Change: Buy >> Neutral
    • Price Target: $4 >> $1.5
  • Estee Lauder (EL)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy >> Neutral
    • Price Target: $140 >> $100
  • Lumen Technologies (LUMN)
    • Brokerage Firm: Wells Fargo
    • Ratings Change: Equal Weight >> Underweight
    • Price Target: $1.75 >> $4
  • Silicon Motion (SIMO)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy >> Underperform
    • Price Target: $90 >> $60
  • Viracta Therapeutics (VIRX)
    • Brokerage Firm: Leerink Partners
    • Ratings Change: Outperform >> Market Perform
    • Price Target: $5 >> $3
  • Vital Energy (VTLE)
    • Brokerage Firm: KeyBanc Capital Markets
    • Ratings Change: Overweight >> Sector Weight
  • Xos (XOS)
    • Brokerage Firm: DA Davidson
    • Ratings Change: Buy >> Neutral
    • Price Target: $17 >> $9
  • Cardlytics (CDLX)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Outperform >> Market Perform
    • Price Target: $5

Coverage Initiated – Friday, August 16, 2024

  • Couchbase (BASE)
    • Brokerage Firm: Piper Sandler
    • Ratings Change: Overweight
    • Price Target: $22
  • Liquidia Technologies (LQDA)
    • Brokerage Firm: Raymond James
    • Ratings Change: Outperform
    • Price Target: $27
  • Y-mAbs Therapeutics (YMAB)
    • Brokerage Firm: Cantor Fitzgerald
    • Ratings Change: Overweight
    • Price Target: $20
  • Two Harbors Investment (TWO)
    • Brokerage Firm: Janney
    • Ratings Change: Buy
    • Price Target: $15

August 15th Upgrades, Downgrades, and More

Upgrades:

  • Dutch Bros (BROS): UBS upgraded from Neutral to Buy; Price Target: $39.
  • Brinker (EAT): KeyBanc Capital Markets upgraded from Sector Weight to Overweight; Price Target: $72.
  • Robinhood Markets (HOOD): Deutsche Bank upgraded from Hold to Buy; Price Target increased from $21 to $24.
  • Medtronic (MDT): UBS upgraded from Sell to Neutral; Price Target increased from $76 to $90.
  • Progressive (PGR): Goldman upgraded from Neutral to Buy; Price Target increased from $230 to $262.

Downgrades:

  • Snowflake (SNOW): Wells Fargo downgraded from Overweight to Equal Weight; Price Target decreased from $200 to $130.
  • Las Vegas Sands (LVS): Argus downgraded from Buy to Hold.
  • Pilgrim’s Pride (PPC): BofA Securities downgraded from Buy to Neutral; Price Target: $47.
  • Bluebirdbio (BLUE): JP Morgan downgraded from Overweight to Neutral.

Coverage Initiated:

  • Advanced Energy (AEIS): Stifel initiated coverage with a Buy rating; Price Target: $135.
  • Tyra Biosciences (TYRA): Piper Sandler initiated coverage with an Overweight rating; Price Target: $33.
  • Valvoline (VVV): Robert W. Baird initiated coverage with an Outperform rating; Price Target: $48.

August 14th Upgrades, Downgrades, and More

Upgrades (August 14, 2024)

  • American Woodmark (AMWD): Wolfe Research – Peer Perform >> Outperform, Price Target: $110
  • Ball Corp (BALL): Robert W. Baird – Neutral >> Outperform, Price Target: $70
  • Cidara Therapeutics (CDTX): H.C. Wainwright – Neutral >> Buy, Price Target: $24
  • Chipotle Mexican Grill (CMG): Wedbush – Neutral >> Outperform, Price Target: $54 >> $58
  • EQT Corp. (EQT): Wells Fargo – Equal Weight >> Overweight, Price Target: $40 >> $42
  • Hudbay Minerals (HBM): Jefferies – Hold >> Buy
  • HUYA (HUYA): Citigroup – Sell >> Buy, Price Target: $2.4 >> $6
  • Illumina (ILMN):
    • Barclays – Underweight >> Equal Weight, Price Target: $125
    • TD Cowen – Hold >> Buy, Price Target: $126 >> $144
  • Johnson Controls (JCI): RBC Capital Mkts – Underperform >> Sector Perform, Price Target: $61 >> $69
  • L’Oreal (LRLCY): Jefferies – Underperform >> Hold
  • Meritage (MTH): Wolfe Research – Peer Perform >> Outperform, Price Target: $230
  • nCino (NCNO): Goldman – Neutral >> Buy, Price Target: $34 >> $42
  • Nkarta (NKTX): Raymond James – Outperform >> Strong Buy, Price Target: $16
  • Starbucks (SBUX):
    • Evercore ISI – In-line >> Outperform, Price Target: $80 >> $120
    • Deutsche Bank – Hold >> Buy, Price Target: $85 >> $118
    • Stifel – Hold >> Buy, Price Target: $80 >> $110
  • Sportradar Group AG (SRAD): Jefferies – Hold >> Buy, Price Target: $12 >> $16
  • Int’l Paper (IP): Argus – Hold >> Buy, Price Target: $52
  • Sea Limited (SE): JP Morgan – Neutral >> Overweight, Price Target: $66 >> $90
  • Hut 8 Mining (HUT): H.C. Wainwright – Sell >> Buy, Price Target: $7.5 >> $13.5
  • FLEX LNG (FLNG): Jefferies – Underperform >> Hold, Price Target: $24
  • Lithium Argentina (LAAC): HSBC Securities – Hold >> Buy
  • Victoria’s Secret (VSCO): Morgan Stanley – Underweight >> Equal-Weight

Downgrades (August 14, 2024)

  • Emerson (EMR): JP Morgan – Overweight >> Neutral, Price Target: $132 >> $115
  • Hudson Pacific Properties (HPP): Wolfe Research – Outperform >> Peer Perform
  • Hershey Foods (HSY): Argus – Buy >> Hold
  • Hexcel (HXL): RBC Capital Mkts – Outperform >> Sector Perform, Price Target: $76 >> $68
  • Intuit (INTU): Morgan Stanley – Overweight >> Equal-Weight, Price Target: $750 >> $685
  • L3Harris (LHX): RBC Capital Mkts – Outperform >> Sector Perform, Price Target: $250 >> $240
  • Medtronic (MDT): Stifel – Buy >> Hold, Price Target: $100 >> $85
  • Marinus Pharmaceuticals (MRNS): Ladenburg Thalmann – Buy >> Neutral
  • Ranpak (PACK): Robert W. Baird – Outperform >> Neutral, Price Target: $10
  • PulteGroup (PHM): Wolfe Research – Outperform >> Peer Perform
  • Playa Hotels & Resorts (PLYA): Citigroup – Buy >> Neutral, Price Target: $12 >> $8
  • ACELYRIN (SLRN): H.C. Wainwright – Buy >> Neutral, Price Target: $18 >> $6
  • IDEX Corp (IEX): Argus – Buy >> Hold

Coverage Initiated (August 14, 2024)

  • DTE Energy (DTE): Ladenburg Thalmann – Buy, Price Target: $131
  • Enova International (ENVA): BTIG Research – Buy, Price Target: $90
  • Korro Bio (KRRO): William Blair – Outperform, Price Target: $180
  • Montrose Environmental Group (MEG): Evercore ISI – Outperform, Price Target: $43
  • VSE Corp (VSEC): Jefferies – Buy, Price Target: $100
  • First Solar (FSLR): Clarksons Platou – Buy, Price Target: $270

August 12th Upgrades, Downgrades, and More

Upgrades:

  • Allstate (ALL): Wells Fargo upgraded from Underweight to Equal Weight; price target increased from $142 to $177.
  • Blend Labs (BLND): Canaccord Genuity upgraded from Hold to Buy; price target raised from $3 to $4.75.
  • Brown & Brown (BRO): Wells Fargo upgraded from Equal Weight to Overweight; price target increased from $94 to $112.
  • Churchill Downs (CHDN): BofA Securities upgraded from Neutral to Buy; price target raised from $145 to $155.
  • Diageo plc (DEO): RBC Capital Markets upgraded from Underperform to Sector Perform.
  • Goldman Sachs BDC (GSBD): Wells Fargo upgraded from Underweight to Equal Weight; price target adjusted from $14 to $12.
  • Robinhood Markets (HOOD): Piper Sandler upgraded from Neutral to Overweight; price target raised from $20 to $23.
  • Liberty Global (LBTYA): BofA Securities upgraded from Underperform to Neutral; price target raised from $15.5 to $21.3.
  • Camden Property (CPT): BofA Securities upgraded from Underperform to Buy; price target increased from $111 to $147.
  • Eli Lilly (LLY): Deutsche Bank upgraded from Hold to Buy; price target set at $1025.
  • Mid-America Apartment (MAA): BofA Securities upgraded from Underperform to Buy; price target raised from $144 to $189.
  • PAR Technology (PAR): Jefferies upgraded from Hold to Buy; price target increased from $45 to $60.
  • Prudential (PRU): Wells Fargo upgraded from Underweight to Equal Weight; no price target provided.
  • Take-Two (TTWO): HSBC Securities upgraded from Hold to Buy; price target set at $179.
  • Zentalis Pharma (ZNTL): Wedbush upgraded from Underperform to Neutral; price target set at $4.
  • Power Integrations (POWI): Northland Capital upgraded from Market Perform to Outperform; price target set at $80.
  • Progressive (PGR): HSBC Securities upgraded from Hold to Buy; price target set at $253.
  • Coherent (COHR): BofA Securities upgraded from Neutral to Buy; price target raised from $65 to $75.
  • PennantPark Floating Rate Capital (PFLT): Maxim Group upgraded from Hold to Buy; price target set at $12.
  • CBIZ (CBZ): Sidoti upgraded from Neutral to Buy; price target increased from $80 to $86.
  • Alcoa (AA): UBS upgraded from Sell to Buy; price target raised from $32 to $38.

Downgrades:

  • Algonquin Power & Utilities (AQN): Wells Fargo downgraded from Overweight to Equal Weight; price target reduced from $8.5 to $6.
  • Brighthouse Financial (BHF): Wells Fargo downgraded from Equal Weight to Underweight; price target reduced from $51 to $40.
  • Bank of Hawaii (BOH): Piper Sandler downgraded from Neutral to Underweight; price target reduced from $70 to $61.
  • Hillenbrand (HI): DA Davidson downgraded from Buy to Neutral; price target reduced from $54 to $33.
  • Janus International Group (JBI): Wolfe Research downgraded from Outperform to Peer Perform.
  • Lion Electric (LEV): DA Davidson downgraded from Buy to Neutral; price target reduced from $1.5 to $1.
  • Pacira BioSciences (PCRX): Multiple downgrades:
    • RBC Capital Markets from Outperform to Sector Perform; price target reduced from $37 to $14.
    • Raymond James from Outperform to Market Perform.
    • JP Morgan from Overweight to Underweight; price target reduced from $45 to $10.
    • Piper Sandler from Overweight to Neutral; price target reduced from $42 to $11.
  • Prologis (PLD): BofA Securities downgraded from Buy to Neutral; no new price target.
  • Piedmont Lithium (PLL): Macquarie downgraded from Outperform to Neutral; price target adjusted from $9.3.
  • Pilgrim’s Pride (PPC): BMO Capital Markets downgraded from Outperform to Market Perform; price target reduced from $46.
  • Qualcomm (QCOM): Wolfe Research downgraded from Outperform to Peer Perform.
  • EchoStar (SATS): JP Morgan downgraded from Neutral to Underweight; price target set at $12.
  • Sylvamo (SLVM): BofA Securities downgraded from Buy to Neutral; price target reduced from $71 to $82.
  • Triumph Group (TGI): Jefferies downgraded from Buy to Hold; price target reduced from $20 to $14.
  • Algonquin Power & Utilities (AQN): Raymond James downgraded from Outperform to Market Perform.
  • Gladstone Land (LAND): Maxim Group downgraded from Buy to Hold.
  • Ballard Power (BLDP): TD Securities downgraded from Hold to Sell.

Coverage Initiated:

  • Arcturus Therapeutics (ARCT): Leerink Partners initiated coverage with an Outperform rating; price target set at $70.
  • Ardent Health Partners (ARDT): Multiple firms initiated coverage with varying ratings:
    • Truist: Buy, $21
    • Leerink Partners: Outperform, $23
    • Mizuho: Outperform, $20
    • JP Morgan: Neutral, $18
    • Morgan Stanley: Overweight, $27
    • RBC Capital Markets: Outperform, $23
    • Citigroup: Buy, $21
    • Stephens: Overweight, $24
    • BofA Securities: Buy, $22
    • Loop Capital: Buy, $18
  • Conagra (CAG): Goldman initiated coverage with a Buy rating; price target set at $36.
  • Hershey Foods (HSY): Goldman initiated coverage with a Sell rating; price target set at $185.
  • J. Jill (JILL): TD Cowen initiated coverage with a Hold rating; price target set at $37.
  • Kellanova (K): Goldman initiated coverage with a Neutral rating; price target set at $75.
  • Kraft Heinz (KHC): Goldman initiated coverage with a Sell rating; price target set at $34.
  • LENZ Therapeutics (LENZ): H.C. Wainwright initiated coverage with a Buy rating; price target set at $38.
  • Summit Therapeutics (SMMT): H.C. Wainwright initiated coverage with a Buy rating; price target set at $16.
  • Solaris Resources Inc. (SLSR): H.C. Wainwright initiated coverage with a Buy rating; price target set at $10.
  • USCB Financial Holdings (USCB): Hovde Group initiated coverage with a Market Perform rating; price target set at $16.
  • Dave, Inc. (DAVE): The Benchmark Company initiated coverage with a Buy rating; price target set at $53.
  • GE Vernova (GEV): HSBC Securities initiated coverage with a Buy rating; price target set at $215.
  • General Mills (GIS): Goldman initiated coverage with a Buy rating; price target set at $76.
  • Mondelez International (MDLZ): Goldman initiated coverage with a Buy rating; price target set at $80.
  • Morningstar (MORN): BMO Capital Markets initiated coverage with an Outperform rating; price target set at $352.
  • Tempus AI (TEM): Piper Sandler initiated coverage with a Neutral rating; price target set at $40.
  • TWFG, Inc. (TWFG): Multiple firms initiated coverage with varying ratings:
    • Keefe Bruyette: Market Perform, $27
    • UBS: Buy, $29
    • RBC Capital Markets: Outperform, $29
    • JP Morgan: Overweight, $26.5
    • Piper Sandler: Overweight, $27
    • Morgan Stanley: Equal-Weight, $23
    • BMO Capital Markets: Outperform, $30
  • GDEV Inc. (GDEV): Noble Capital Markets initiated coverage with an Outperform rating; price target set at $6.